This early-phase study tests whether a bicalutamide implant placed directly into the prostate can replace standard hormone shots for men with localized prostate cancer receiving radiation. About 20 participants with intermediate- or high-risk cancer will receive the implant plus …
Phase: PHASE1 • Sponsor: Alessa Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC